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Background. Following infection with viruses, bacteria or protozoan parasites, naı ¨ve antigen-specific CD8
+ T cells undergo
a process of differentiation and proliferation to generate effector cells. Recent evidences suggest that the timing of generation
of specific effector CD8
+ T cells varies widely according to different pathogens. We hypothesized that the timing of increase in
the pathogen load could be a critical parameter governing this process. Methodology/Principal Findings. Using increasing
doses of the protozoan parasite Trypanosoma cruzi to infect C57BL/6 mice, we observed a significant acceleration in the timing
of parasitemia without an increase in mouse susceptibility. In contrast, in CD8 deficient mice, we observed an inverse
relationship between the parasite inoculum and the timing of death. These results suggest that in normal mice CD8
+ T cells
became protective earlier, following the accelerated development of parasitemia. The evaluation of specific cytotoxic
responses in vivo to three distinct epitopes revealed that increasing the parasite inoculum hastened the expansion of specific
CD8
+ cytotoxic T cells following infection. The differentiation and expansion of T. cruzi-specific CD8
+ cytotoxic T cells is in fact
dependent on parasite multiplication, as radiation-attenuated parasites were unable to activate these cells. We also observed
that, in contrast to most pathogens, the activation process of T. cruzi-specific CD8
+ cytotoxic T cells was dependent on MHC
class II restricted CD4
+ T cells. Conclusions/Significance. Our results are compatible with our initial hypothesis that the
timing of increase in the pathogen load can be a critical parameter governing the kinetics of CD4
+ T cell-dependent expansion
of pathogen-specific CD8
+ cytotoxic T cells.
Citation: Tzelepis F, Persechini PM, Rodrigues MM (2007) Modulation of CD4
+ T Cell-Dependent Specific Cytotoxic CD8
+ T Cells Differentiation and
Proliferation by the Timing of Increase in the Pathogen Load. PLoS ONE 2(4): e393. doi:10.1371/journal.pone.0000393
INTRODUCTION
MHC class Ia-restricted CD8
+ T cells are important mediators of
the adaptive immune response against infections caused by
intracellular microorganisms. Following infection with certain
viruses, bacterias or parasites, naı ¨ve antigen-specific CD8
+ T cells
go through a process of fast differentiation and proliferation,
generating effector cytotoxic cells (expansion phase). These
effector cells circulate between lymphoid and non-lymphoid
tissues to restrain the multiplication of the infectious pathogen.
Following pathogen elimination, the number of specific effector
CD8
+ T cells is drastically reduced (contraction phase) and the
establishment of a long-lived population of memory T cells
responsible for perpetuating immunity against re-infection takes
place. This kinetics of effector CD8
+ T cell expansion, contraction
and establishment of a memory population has been fairly well
reproduced and it is being thoroughly studied in a number of
experimental models, including virus, bacterias and protozoan
parasites (reviewed in ref. 1–3).
Using these experimental models, it was possible to establish
that specific CD8
+ T cells differentiate and proliferate very quickly
reaching a peak between days 4 and 8 after immunization with
either lymphocytic choriomeningitis virus (LCMV), influenza
virus, vaccinia virus, Listeria monocytogenes or Plasmodium yoelli [4–
9]. Recent studies in mice infected with Toxoplasma gondii,
Mycobacterium bovis bacille Calmette-Guerin (BCG), Trypanosoma
cruzi and Salmonella typhimurium described significantly different
kinetics of differentiation and proliferation of specific CD8
+ T
cells. In the case of T. gondii, CD8
+ T cells specific for a transgenic
epitope became detectable only 10 days after challenge, and the
maximum number of epitope-specific T cells peaked at day 23
[10]. Similarly, in mice injected with recombinant S. typhimurium or
BCG the peak response to the transgenic epitope was day 21
st or
30
th following challenge, respectively [11,12].
We recently described the kinetics of parasite-specific cytotoxic
CD8
+ T cell responses following mouse infection with the human
protozoan parasite Trypanosoma cruzi [13]. An interesting finding
was that the initial inoculum of T. cruzi did not drive the
differentiation and proliferation of effector CD8
+ T cells. The
expansion phase of specific splenic CD8
+ T cells occurred after in
vivo multiplication of parasites, between days 9 and 15 after i.p.
challenge of C57BL/6 mice with 10
4 parasites of the Y strain.
More recently, Martin et al., (2006) confirmed and extended our
results in studies using different T. cruzi strains, which revealed that
the peak of parasite epitope-specific CD8
+ T cells could vary from
14 to 24 days post-infection [14].
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PLoS ONE | www.plosone.org 1 April 2007 | Issue 4 | e393The results obtained during T. gondii, BCG, S. typhimurium or T.
cruzi infections sharply differed from the observations made in
mice infected with LCMV, vaccinia, influenza, L. monocytogenes or P.
yoelli and raised questions on the possible mechanisms controlling
the kinetics of differentiation and proliferation following infection
with different pathogens.
One mechanism that could influence the kinetics of specific
CD8
+ T cells differentiation and proliferation is the amount of
antigen and parasite-derived adjuvant both of which accumulate
during the infection. Immediately after the initial infectious
inoculum, the amount of antigen and parasite adjuvant available
for CD8
+ T-cell priming may be limited, however both will
increase after pathogen multiplication, and then may reach
a certain threshold necessary to promote the maturation of antigen
presenting cells (APC) - in the case of the adjuvant molecule - and
trigger the activation of naı ¨ve CD8
+ T cells, in the case of the
antigen. If this hypothesis is correct, the timing of increase of
pathogen adjuvant/antigen would be a key parameter governing the
process of CD8
+ T cell differentiation and expansion.
The aim of the present study was to determine whether
modulation of the parasite load within a certain period of time can
in fact alter the activation of effector/protective CD8
+ Tc e l l s .F o r
this purpose, we used an experimental model where C57BL/6 mice
were challenged with different doses of parasite of the Y strain of
Trypanosoma cruzi. This strategy allowed us to modulate the timing of
increase in the parasite load and determine the effect it may have on
the in vivo differentiation and proliferation of effector/protective
CD8
+ T cells. Using this experimental model, we were able to lend
support to the hypothesis that the timing of accumulation of the
parasite load can be a key factor influencing the differentiation and
proliferation of CD4
+ T cell-dependent specific CD8
+ cytotoxic T
cells following infection with a human pathogen.
METHODS
Mice and parasites
Female 8 to 10-week-old wild type (WT) C57BL/6, CD8a
deficient C57BL/6 (CD8 KO), MHC-II deficient C57BL/6
(MHC-II KO), CD4 deficient C57BL/6 (CD4 KO), p40 deficient
C57BL/6 (IL-12 KO), wild type 129 and 129 deficient for the
IFN-I receptor (IFN-I receptor KO) were obtained from
University of Sa ˜o Paulo. Perforin deficient C57BL/6 (Perforin
KO) mice were bred on our own facility.
Parasites of the Y strain of T. cruzi were used in this study [13].
Bloodstream trypomastigotes were obtained from the plasma of
A/Sn mice infected 7 days earlier. The concentration of parasites
was adjusted and each mouse was inoculated intraperitoneally
(i.p.) with 0.2 mL containing the indicated amount of trypomas-
tigotes. Parasite development was monitored by counting the
number of bloodstream trypomastigotes in 5 ml of fresh blood
collected from the tail vein [13]. When the parasitemia was above
10
5 trypomastigotes per mL, blood samples were diluted and the
number of parasites estimated with the aid of a hemacytometer.
Radiation-attenuated parasites were obtained by exposing them to
gamma-irradiation (100 krads).
Immunological assays
For the in vivo cytotoxicity assays, C57BL/6 splenocytes were
divided into two populations and labeled with the fluorogenic dye
carboxyfluorescein diacetate succinimidyl diester (CFSE Molecu-
lar Probes, Eugene, Oregon, USA) at a final concentration of
5 mM (CFSEhigh) or 0.5 mM (CFSElow). CFSEhigh cells were pulsed
for 40 min at 37uC with 1 mM of the H-2K
b ASP-2 peptide
(VNHRFTLV), or TsKb-18 (ANYKFTLV) or TsKb-20
(ANYDFTLV). CFSElow cells remained unpulsed. Subsequently,
CFSEhigh cells were washed and mixed with equal numbers of
CFSElow cells before injecting intravenously (i.v.) 15 to 20610
6
total cells per mouse. Recipient animals were mice that had been
infected or not with T. cruzi. Spleen cells of recipient mice were
collected 20 h after transfer, fixed with 3.7% paraformaldehyde
and analyzed by fluorescence-activated cell sorting (FACS), using
a Facscalibur Cytometer (BD, Mountain View, CA). The
percentage of specific lysis was determined using the formula:
1{
% CFSEhigh infected

% CFSElow infected
%CFSEhigh naive

%CFSElow naive
|100%: ð1Þ
The ELISPOT assay for enumeration of Interferon-gamma
(IFN-c) producing cells was performed essentially as described
earlier [15].
Statistical analysis
The values of were compared by One-Way Anova followed by
Tukey HSD tests available at the site http://faculty.vassar.edu/
lowry/VassarStats.html. The LogRank test was used to compare the
mouse survival rate after challenge with T. cruzi. The differences
were considered significant when the P value was ,0.05.
RESULTS
In initial studies we investigated the development of T. cruzi
parasitemia in wild type C57BL/6 mice challenged i.p. with
different doses of trypomastigotes (10
2,1 0
3,1 0
4 or 10
5 parasites
per mouse). As shown in figure 1, infection with 10
2 parasites
generated a parasitemia that could be first detected at day 8 and
peaked at day 11 post challenge. Doses of 10
3,1 0
4 or 10
5 parasites
hastened the initial detection of parasitemia to days 5, 4 and 3,
respectively. The peak parasitemia in mice receiving the highest
parasite doses was also earlier, at days 9, 8 or 5 respectively. The
magnitude of the peak parasitemias between the different mice
groups was not significantly different when comparing groups of
mice infected with 10
5 or 10
4. Similarly, no difference was found
when comparing groups of mice infected with 10
3 or 10
2. Mice
infected with 10
3 parasites presented a peak parasitemia lower
(P,0.05) than the mouse group infected with 10
4 but not with 10
5
parasites. In repeated experiments, mice infected with 10
2
parasites presented a peak parasitemia lower than mouse groups
infected with 10
4 or 10
5 (P,0.01 in both cases).
In view of these results, we concluded that there is an inverse
relationship between parasite inoculum and the timing of the
development of T. cruzi parasitemia, a feature that had not been
described. In addition, we observed that the peak parasitemia did
not differ significantly among groups of mice injected with 10
3,
10
4,o r1 0
5 parasites. Mice infected with 10
2 parasites consistently
presented lower peak parasitemia than animals challenged with
much higher parasite doses (10
4 or 10
5 parasites per mouse). In
spite of the fact that the parasitemia reached the peak earlier when
the parasite inoculum was increased, these mice were capable of
controlling the infection and survived the challenge. Because in
this mouse model of infection CD8
+ T cells are critical for survival
[13], the fact that animals injected with increasing parasite
inoculum survived infection suggested that they were able to
develop protective immunity in spite of increasing the infective
dose. To determine whether protective immunity dependent on
CD8
+ T cells could indeed be developed in these animals, we
compared the parasitemia and mortality of wild type and CD8
KO mice following infection with different doses of parasites. As
shown in figure 2A, when comparing infected wild type and CD8
CD8
+ T Cell Expansion
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significantly different. Theseresults indicated that CD8
+ Tc e l l sw e r e
not important for parasite control during that period regardless of
the parasite dose used for challenge. After the day of the peak
parasitemia, wild type mice rapidly controlled the number of
parasites in the blood. In sharp contrast, CD8 KO mice were unable
to control the parasitemia, became ill and eventually died.
When we compared the timing of death of each group of CD8
KO mice, we observed an inverse relationship between the size of
parasite inoculum and the timing of death. Statistical analysis
revealed a significant difference among the groups of infected CD8
KO mice (P#0.01 in all cases, Fig. 2B). As wild type mice
survived, these results clearly confirmed the importance of CD8
+
T cells as a protective mechanism in mice infected with different
doses of parasite. These results also suggest that the activation of
protective CD8
+ T cells in wild type C57BL/6 mice takes place
earlier as the parasite inoculum is increased.
To determine whether there was an inverse relationship
between the parasite inoculum used for infection and the timing
of expansion of specific CD8
+ cytotoxic T cells, we characterized
the kinetics of effector CD8
+ T cell development. For this purpose
we used a functional cytotoxic assay which measures the in vivo
elimination of target cells coated with peptide VNHRFTLV [13].
The phenotype of effector cells mediating peptide-specific in vivo
cytotoxicity was established earlier as being CD8
+ T cells [13]. As
shown in Fig. 3A, at day 5 post-infection, none of the mouse
groups presented peptide-specific cytotoxicity. At day 10 day post-
infection, we observed a direct correlation between the size of
parasite inoculum and intensity of the in vivo cytotoxicity (Fig. 3B).
By day 15
th, groups of mice infected with 10
3,1 0
4 or 10
5 parasites
had reached their maximum cytotoxicity (close to 100% specific
lysis). In contrast animals infected with 10
2 parasites still displayed
only ,50% cytotoxic activity (Fig. 3C). By day 30
th post-infection,
theinvivocytotoxicityreachedfrequenciescloseto100%inallmouse
groups (Fig. 3D). The in vivo cytotoxicity continued at a high level in
all infected groups until tested 100 days after challenge (Fig. 3E).
IFN-c ELISPOT assays confirmed that at day 5 post-infection
few peptide-specific T cells were detected in mice infected with
increasing doses of T. cruzi. A direct correlation between the size of
parasite inoculum and the number of peptide-specific cells was
clearly evident by day 10 post-infection. By day 15
th or 30
th, in all
mice groups we detected a high frequency of IFN-c producing
specific T cells (Fig. 3F).
To evaluate whether the results described above could also be
extended to other parasite epitopes, we evaluated the kinetics of
the in vivo cytotoxicity specific for two other sub-dominant epitopes
(TsKb-18 and TsKb-20, ref. 14). We found that the kinetics of
cytotoxicity for both sub-dominant epitopes was also dependent on
the dose of parasites used for the challenge (Fig. 4).
The results presented above established an inverse relationship
between the parasite inoculum and the timing of cytotoxic CD8
+
T cells differentiation and proliferation. However, it was not clear
whether this event was in fact dependent on parasite multiplication
or depended solely on dose of parasite used for challenge. To
address this question, we challenged mice with irradiated or non-
irradiated parasites. Irradiated parasites maintain their viability as
assessed by their motility and capacity to infect host cells in vitro.
However, they are unable to multiply (in vitro or in vivo) and
establish an infection as determined by absence of parasitemia.
Mice challenged with 10
3 or 10
4 irradiated parasites did not
develop detectable in vivo cytotoxic activity or IFN-c producing
cells (Fig. 5A and 5B, respectively). In contrast, animals challenged
with 10
3 or 10
4 non-irradiated parasites developed strong cyto-
toxic responses and peptide-specific IFN-c producing cells (Fig. 5A
and 5B, respectively). This result suggested that parasite replica-
tion was indeed an important factor to promote differentiation and
proliferation of cytotoxic T cells.
Because certain genetically deficient mice are highly susceptible
to T. cruzi infection, and die before specific CD8
+ T cells could be
detected, it is difficult to study the importance that certain cells/
molecules may have on proliferation and development of effector
functions of CD8
+ cytotoxic T cells following T. cruzi infection.
However, the fast development of cytotoxic T cells observed in
mice infected with large doses of T. cruzi (10
5 parasites per mouse),
allowed us to study some of the molecules of the immune system
that could play an important role in the development of protective
CD8
+ cytotoxic T cells. Using this strategy, we were able to study
whether genetically deficient mice lacking MHC-II, CD4, IL-12,
perforin or IFN-I receptor were capable of developing specific
CD8
+ cytotoxic T cell responses. We found that MHC-II or CD4
KO mice developed negligible levels of specific cytotoxicity in vivo
(Fig. 6A and B, respectively). In contrast, IL-12 KO or IFN-I
receptor KO mice developed normal levels of specific cytotoxicity
in vivo (Fig. 6A and 6C, respectively). Cytotoxicity mediated by
CD8
+ T cell responses in Perforin KO mice were significantly
reduced (,75%) compared to control wild type animals. The
results of these studies clearly indicate that MHC-II and CD4 are
key molecules for the induction of an effective cytotoxic CD8
+ T
cell response following T. cruzi infection.
DISCUSSION
Sufficient amounts of pathogen-derived adjuvant to mature APC
and antigen to trigger T cells are possibly among the critical steps
Figure 1. Trypomastigote-induced parasitemia in C57BL/6 mice
challenged with different doses of trypomastigotes of T. cruzi.
C57BL/6 mice were infected i.p. with 10
2,10
3,1 0
4 or 10
5 bloodstream
trypomastigotes of the Y strain of T. cruzi. Parasitemia was followed
daily from days 0 to 14 after challenge. The results represent the mean
of 5–6 mice6SD. At the peak of infection, the parasitemia of mice
infected with each different dose was compared by One-way Anova
and Tukey HSD tests. The results of the comparisons were as follows: i)
10
2610
3, Non-Significant (NS); ii) 10
2610
4, P,0.01; iii) 10
2610
5, P,0.01;
iv) 10
3610
4, P,0.05; v) 10
3610
5, NS; vi) 10
4610
5, NS. Results are
representative of two independent experiments.
doi:10.1371/journal.pone.0000393.g001
CD8
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PLoS ONE | www.plosone.org 3 April 2007 | Issue 4 | e393Figure 2. Infection in WT C57BL/6 or CD8 KO mice challenged with different doses of T. cruzi. Groups of WT C57BL/6 or CD8 KO were infected i.p.
with 10
2,10
3,1 0
4 or 10
5 bloodstream trypomastigotes of the Y strain of T. cruzi. (A) Course of infection, estimated by the number of trypomastigotes
per mL of blood. Results represent the mean values of 4–5 mice6SD. The parasitemias of WT C57BL/6 or CD8 KO mice were compared by One-way
Anova. Asterisks denote statistically significant differences (P,0.05). (B) Kaplan-Meier curves for survival of WT C57BL/6 or CD8 KO infected mice with
different doses of parasites. Statistical analyses were performed using LogRank test comparing the different mouse groups. Initially, we compared
groups of WT C57BL/6 infected with different doses. The results of the comparison showed no statistically significant differences among them.
Subsequently, we compared WT C57BL/6 or CD8 KO infected with each different dose of parasites. The results of the comparison showed statistically
significant differences in between C56BL/6 or CD8 KO challenged with each parasite dose (P,0.0001, in all cases). Finally, statistical analyses were
performed comparing the groups of CD8 KO infected with different doses. The results of the comparison were as follows: i) CD8 KO 10
26CD8 KO 10
3
(P=0.0025); ii) CD8 KO 10
26CD8 KO 10
4 (P=0.0046); iii) CD8 KO 10
26CD8 KO 10
5 (P=0.0016); iv) CD8 KO 10
36CD8 KO 10
4 (P=0.01); v) CD8 KO
10
36CD8 KO 10
5 (P=0.0035); vi) CD8 KO 10
46CD8 KO 10
5 (P=0.0082).
doi:10.1371/journal.pone.0000393.g002
CD8
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+ cytotoxic
T cells. However, during infection with different pathogens, it is
not clear the point at which the amount of adjuvant and antigen
reach the necessary threshold to induce APC maturation and T
cell activation. Considering that in most cases the initial pathogen
inoculum is limited, pathogen multiplication may be a critical step
in this process. In our experimental model, after infection with
viable irradiated parasites of T. cruzi, we were unable to detect
differentiation and proliferation of cytotoxic CD8
+ T cells (Fig. 5).
This result suggests that T. cruzi multiplication is critical to
generate sufficient amounts of parasite adjuvant for the maturation
of APC, and antigens for T cell activation. Our result contrasts
with the data published using sporozoites of P. yoelii. In this case,
relatively small doses (10
4–10
5 parasites per mouse) of non-
replicating radiation-attenuated parasites efficiently prime effec-
tor/protective CD8
+ T cells [16]. As for Listeria, non-replicating
Figure 3. Kinetics of specific CD8
+ T-cell mediated immune responses following challenge with T. cruzi. Groups of C57BL/6 mice were challenged
or not i.p. with 10
2,10
3,1 0
4 or 10
5 bloodstream trypomastigotes of the Y strain of T. cruzi. Panels A to E - At the indicated days, the in vivo cytotoxic
activity against target cells coated with peptide VNHRFTLV was determined as described in the Methods Section. The results represent the mean of 4
mice6SD per group. Asterisks denote statistically significant differences when we compared T. cruzi challenged with control mice (P,0.05). Panel F-
At the indicated days, IFN-c producing spleen cells specific to the peptide VNHRFTLV were estimated by the ELISPOT assay. The results represent the
mean number of peptide-specific spot forming cells (SFC) per 10
6 splenocytes6SD (n=4). Results are representative of two or more independent
experiments.
doi:10.1371/journal.pone.0000393.g003
CD8
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+ T-cell mediated immune responses specific for sub-dominant epitopes in C57BL/6 mice. Groups of C57BL/6 mice were
challenged or not i.p. with 10
2,10
3,1 0
4 or 10
5 bloodstream trypomastigotes of the Y strain of T. cruzi. At the indicated days, the in vivo cytotoxic
activity against target cells coated with peptide TsKb-18 or TsKb-20 was determined as described in the Methods Section. The results represent the
mean of 4 mice6SD per group. Asterisks denote statistically significant differences when we compared T. cruzi challenged with control mice
(P,0.05). ND=Not done. Results are representative of two or more independent experiments.
doi:10.1371/journal.pone.0000393.g004
CD8
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protective CD8
+ T cells. However, large doses of bacteria (10
9 per
mouse) were employed. This inoculum size of radiation-attenuated
bacterias was considerably higher than the inoculum of 10
4 non-
irradiated bacterias per mouse used to prime protective CD8
+ T
cells [17].
While the notion that the timing of accumulation of pathogen-
derived antigen/adjuvant may influence the kinetics of expansion
of effector CD8
+ T cells appears to be reasonable, few experi-
mental models provide an opportunity to evaluate this important
aspect of the CD8
+ T cell response. Our initial observation that
increasing doses of T. cruzi caused an acceleration of T. cruzi
parasitemia without increasing mouse susceptibility provided
a suitable experimental model to study this issue. As observed
with T. cruzi infection, an inverse relationship was described
Figure 5. Specific cytotoxicity in C57BL/6 mice challenged with
irradiated or non-irradiated trypomastigotes of T. cruzi. Groups of
C57BL/6 mice were challenged or not i.p. with 10
3 or 10
4 irradiated or
non-irradiated bloodstream trypomastigotes of the Y strain of T. cruzi.
A) Fifteen days after challenge, the in vivo cytotoxic activity against
target cells coated with peptide VNHRFTLV was determined. The results
represent the mean of 4 mice6SD per group. B) Fifteen days after
challenge, IFN-c producing spleen cells specific to the peptide
VNHRFTLV were estimated by the ELISPOT assay. The results represent
the mean number of SFC per 10
6 splenocytes6SD (n=4). Asterisks
denote statistically significant differences (P,0.05) when we compared
mice challenged with irradiated or non-irradiated trypomastigotes of T.
cruzi. Results are representative of two independent experiments.
doi:10.1371/journal.pone.0000393.g005
Figure 6. Specific cytotoxicity in WT or genetically deficient mice
challenged with T. cruzi. Groups of WT C57BL/6 (n=4), WT 129 mice
(n=4), MHC-II KO (n=4), perforin KO (n=8), CD4 KO (n=4), IL-12 KO
(n=4), and IFN-I receptor KO (n=4) were challenged or not i.p. with 10
5
bloodstream trypomastigotes of the Y strain of T. cruzi. Ten days after
challenge, the in vivo cytotoxic activity against target cells coated with
peptide VNHRFTLV was determined. The results represent the mean of
the above indicated number of mice6SD per group. The in vivo
cytotoxicity was compared by One-way Anova and Tukey HSD tests.
The results of the comparisons were as follows: i) WT C57BL/66MHC-II
KO (P,0.01); ii) WT C57BL/66Perforin KO (P,0.01); iii) WT C57BL/
66CD4 KO (P,0.01); iv) WT C57BL/66IL-12 KO (NS); v) WT 1296IFN-I
receptor KO (NS). Results are representative of two or more in-
dependent experiments.
doi:10.1371/journal.pone.0000393.g006
CD8
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accumulation of viral load in the lung. However, in this
experimental model, the rapid increase in the viral load augmented
the apoptosis of CD8
+ T cells mediated by Fas/FasL interaction,
causing a reduction in the in vivo cytotoxicity mediated by CD8
+ T
cells and and increased death rate in mice which received larger
viral doses [18]. Differently, in our T. cruzi model we observed that
increasing the size of parasite inoculum accelerated the parasitemia
and the timing of differentiation and expansion of cytotoxic CD8
+
T cells (Fig. 3). However, the different doses of parasite did not
modified the final magnitude of the specific CD8
+ T cell response
as measured by the in vivo cytotoxicity or the ELISPOT assay
(Fig. 3). Therefore, we concluded that differently to the influenza
virus system, no inhibitory activity was generated in T. cruzi
infection by the fast pace of parasite adjuvant/antigen accumu-
lation in C57BL/6 mice.
The curves of parasitemia observed in WT C57BL/6 or CD8
KO mice challenged with different parasite doses, strongly suggest
that protective CD8
+ T cells are important for mouse survival only
after the parasitemia reached a peak (Fig. 1 and 2). Until that day,
the amounts of parasites in the blood of both, WT C57BL/6 and
CD8 KO mice, were similar (Fig. 2, ref. 13). After the peak
parasitemia, a rapid reduction in the number of blood parasites
was observed in WT mice while CD8 KO mice failed to control
parasite growth, became severely ill, and eventually died.
Confirmation of the importance of CD8
+ T cells in the period
after the peak parasitemia was obtained in experiments in which
we estimated the presence of cytotoxic T cells in vivo. For example,
while the peak parasitemia of mice challenged with 10
5 parasites
was reached 5 days post-infection, no peptide-specific cytotoxicity
was detected at that day (Fig. 3A). However, 5 days later, the in
vivo cytotoxicity was already 100% indicating that specific CD8
+ T
cells expanded vigorously during that period. Essentially the same
sequence of events is observed in mice challenged with different
doses of parasites. Based on these observations, we concluded that
following challenge of naı ¨ve hosts with parasites of the Y strain of
T. cruzi, the differentiation and expansion of splenic antigen-
specific effector CD8
+ T cells occurs after the peak parasitemia.
These results are in close agreement with the data published by us
and others using 4 different T. cruzi epitopes in two different mouse
strains [13,14]. We consider that our observations are consistent
with the interpretation that the amount of T. cruzi antigen
available before the peak of parasitemia is limited. When the
parasitemia reaches its peak, the threshold for the level of
adjuvant/antigen requirement may be achieved and only then,
the triggering and fast activation of naı ¨ve CD8
+ T cells may occur.
Studies performed in mice infected with LCMV or L. monocytogenes
described comparable timing for expansion of specific CD8
+ T
cells i.e., the peak of viral or bacterial numbers occurs approximately
2–3 days after infection. The peak of CD8
+ Tc e l lr e s p o n s ew a s
approximately 5 days later at day 7–8
th post-infection [1,2].
In the last part of our study, considering that a rapid induction
of T. cruzi-specific CD8
+ T cells occurred after administration of
a large inoculum of parasites, we evaluated the importance that
certain molecules/cells may have on differentiation/proliferation
and effector function of specific CD8
+ T cells following T. cruzi
infection. For this purpose, we used genetically deficient mouse
strains that are described as highly susceptible to infection with T.
cruzi such as MHC-II KO, CD4 KO, IL-12 KO and perforin KO
[13,19–22]. MHC II KO or CD4 KO mice failed to develop
peptide-specific cytotoxicity. We therefore concluded that MHC
II-restricted CD4
+ T cells are important for the maturation and/
or expansion of T. cruzi specific cytotoxic CD8
+ T cells.
Our results indicating that CD8
+ T cells responses against
T.cruzi are critically dependent on CD4
+ T cells differ from most
pathogens. Following viral or bacterial infections, the maturation
and expansion of specific CD8
+ T cells are not critically dependent
on CD4
+ T cells [23–29]. Similarly, CD4
+ T cells are not required
for the initial expansion of CD8
+ T cells specific for epitopes
expressed by the protozoan parasites P. yoelii or T. gondii
[11,30,31]. The precise role for MHC II-restricted CD4
+ T cells
during the process of CD8
+ T cell activation in our model has yet
to be investigated. An intriguing possibility is that CD4
+ T cells
can license dendritic cells for the activation of highly cytotoxic
CD8
+ T cells detected by an in vivo assay [32].
Using IL-12 or IFN-I receptor KO mice, we observed that
neither IL-12 nor IFN type I are critically important for the
efficient maturation and expansion of T. cruzi-specific cytotoxic
CD8
+ T cells. Our results contrasts with previous observation that
IL-12 can provide an important third signal that, in addition to the
engagements of TCR-MHC and CD28-B7, it could provide an
optimal environment for the efficient cytotoxic CD8
+ T cells
differentiation and expansion [33–35].
Perforin KO mice were also severely impaired in their ability to
eliminate peptide-coated targets in vivo. The low level killing
detected in the absence of perforin may represent the contribution
of perforin-independent killing mechanisms. Considering our
previous results indicating that perforin KO mice are highly
susceptible to infection with parasites of the Y strain of T. cruzi,w e
propose that the perforin-dependent granule exocytosis pathway
represent an important mechanism of protection against T. cruzi
infection. These results are in agreement with some viral models
describing perforin as a key molecule for resistance against viral
infection and mediating in vivo lysis of peptide-coated target cells
[36,37]. However, they differ with the observations made for other
protozoan parasites in which perforin KO mice have been shown
to develop protective CD8
+ T cell mediated immunity [38–40].
In summary, our study provides new insights regarding the
requirements for the differentiation and expansion of cytotoxic
CD8
+ T cells during experimental infection with a human
protozoan parasite. Using this experimental model, we determined
the importance of parasite load and MHC-II restricted CD4
+ T
cells for the maturation and expansion of highly cytotoxic CD8
+ T
cells. Also, it established an important role for perforin as
a mediator of the in vivo cytotoxicity against parasite-infected cells.
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